Law channel feed

SEC jumps in­to the Fi­bro­Gen fi­as­co with a sub­poe­na, prob­ing car­dio da­ta ma­nip­u­la­tion

4 years ago
FDA+

Broad In­sti­tute lands ma­jor vic­to­ry in CRISPR patent fight over UC Berke­ley, No­bel win­ners

4 years ago
Cell/Gene Tx

Vi­a­tris agrees to pay $264M to set­tle EpiPen class ac­tion case

4 years ago
Pharma

De­vel­op­ers of a key mR­NA de­liv­ery tech, seek­ing a piece of Mod­er­na's Covid rich­es, sue for patent in­fringe­ment

4 years ago
Pharma

Pfiz­er drops case against ex-staffer ac­cused of steal­ing trade se­crets — in­clud­ing de­tails about Covid-19 vac­cine

4 years ago
People
Pharma

Bla­tant abuse of Chap­ter 11? J&J says its use of 'Texas two-step' is all about fair­ness

4 years ago
Pharma
First page Previous page 35363738
A service from the Financial Times